Y Intercept Hong Kong Ltd Has $2.30 Million Position in The Clorox Company $CLX

Y Intercept Hong Kong Ltd trimmed its stake in shares of The Clorox Company (NYSE:CLX) by 79.6% during the third quarter, HoldingsChannel reports. The fund owned 18,676 shares of the company’s stock after selling 72,707 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Clorox were worth $2,303,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Clorox by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after buying an additional 514 shares during the period. Woodline Partners LP raised its position in Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after buying an additional 7,465 shares during the last quarter. V Square Quantitative Management LLC lifted its stake in Clorox by 26.4% in the 2nd quarter. V Square Quantitative Management LLC now owns 4,442 shares of the company’s stock valued at $533,000 after acquiring an additional 929 shares in the last quarter. PFG Investments LLC boosted its position in Clorox by 39.7% during the 2nd quarter. PFG Investments LLC now owns 5,802 shares of the company’s stock worth $697,000 after acquiring an additional 1,648 shares during the last quarter. Finally, Pacific Point Advisors LLC grew its stake in shares of Clorox by 2.7% during the 2nd quarter. Pacific Point Advisors LLC now owns 9,686 shares of the company’s stock worth $1,163,000 after acquiring an additional 259 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

CLX has been the topic of a number of research reports. Citigroup cut their price objective on shares of Clorox from $120.00 to $109.00 and set a “neutral” rating on the stock in a research report on Wednesday, December 17th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research note on Friday, January 9th. Rothschild & Co Redburn reduced their price objective on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. UBS Group decreased their price objective on Clorox from $119.00 to $115.00 and set a “neutral” rating for the company in a report on Wednesday, January 14th. Finally, Bank of America dropped their target price on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, thirteen have given a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $122.19.

Clorox Trading Down 3.9%

Shares of NYSE:CLX opened at $108.83 on Thursday. The Clorox Company has a 52-week low of $96.66 and a 52-week high of $161.45. The company has a debt-to-equity ratio of 18.01, a quick ratio of 0.50 and a current ratio of 0.76. The company has a market capitalization of $13.28 billion, a P/E ratio of 17.08, a price-to-earnings-growth ratio of 0.56 and a beta of 0.58. The company has a 50-day simple moving average of $104.50 and a 200 day simple moving average of $114.46.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same quarter in the prior year, the company earned $1.86 earnings per share. The business’s revenue for the quarter was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be issued a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 annualized dividend and a yield of 4.6%. Clorox’s dividend payout ratio (DPR) is currently 77.86%.

Insider Buying and Selling

In related news, Director Pierre R. Breber acquired 4,000 shares of the firm’s stock in a transaction on Friday, November 21st. The shares were purchased at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the acquisition, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.63% of the stock is currently owned by company insiders.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.